ID   G3S1
AC   CVCL_5507
DR   Wikidata; Q54835396
RX   PubMed=19444860;
RX   PubMed=20198326;
CC   Population: Caucasian.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5499 ! EM-G3
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
RX   PubMed=19444860; DOI=10.1002/sca.20146;
RA   Vesely P., Rosel D., Pankova D., Tolde O., Blase C., Matouskova E.,
RA   Folk P., Brabek J., Bereiter-Hahn J.;
RT   "Confocal microscopy reveals Myzitiras and Vthela morphotypes as new
RT   signatures of malignancy progression.";
RL   Scanning 31:102-106(2009).
//
RX   PubMed=20198326; DOI=10.3892/ijo_00000560;
RA   Tolde O., Rosel D., Mierke C.T., Pankova D., Folk P., Vesely P.,
RA   Brabek J.;
RT   "Neoplastic progression of the human breast cancer cell line G3S1 is
RT   associated with elevation of cytoskeletal dynamics and upregulation of
RT   MT1-MMP.";
RL   Int. J. Oncol. 36:833-839(2010).
//